Table 1 Baseline demographic and clinical characteristics
Characteristic | Total (n = 16797) | DM group (n = 4713) | CM group (n = 12084) | P value |
|---|---|---|---|---|
Patient demographics | ||||
Age, y, mean ± SD | 63.4 ± 11.6 | 63.9 ± 11.9 | 63.2 ± 11.5 | 0.002 |
Age≥75 yrs | 17.8% | 20.4% | 16.8% | <0.001 |
Women | 30.3% | 30.6% | 30.2% | 0.602 |
Risk factors | ||||
BMI, kg/m2, mean ± SD | 25.89 ± 4.37 | 26.45 ± 4.60 | 25.67 ± 4.25 | <0.001 |
Current smoker | 41.5% | 41.9% | 41.3% | 0.507 |
Alcohol consumption | 46.7% | 47.3% | 46.5% | 0.346 |
Hypertension | 60.8% | 60.5% | 60.8% | 0.732 |
Diabetes | 32.7% | 32.9% | 32.5% | 0.626 |
Hyperlipemia | 27.8% | 29.2% | 27.2% | 0.008 |
Comorbidities | ||||
Chronic heart failure | 16.3% | 17.7% | 15.8% | 0.002 |
Stroke | 13.5% | 14.3% | 13.2% | 0.055 |
Peripheral vascular disease | 3.9% | 4.2% | 3.8% | 0.278 |
Renal failure | 5.6% | 6.0% | 5.4% | 0.128 |
Peptic ulcer | 16.9% | 18.7% | 16.2% | <0.001 |
Hospitalization characteristics | ||||
HR, bpm, mean ± SD | 69.3 ± 10.5 | 73.2 ± 10.4 | 67.7 ± 10.2 | <0.001 |
SBP, mmHg, mean ± SD | 129.0 ± 13.8 | 126.1 ± 15.6 | 130.2 ± 12.8 | <0.001 |
DBP, mmHg, mean ± SD | 74.9 ± 9.8 | 75.2 ± 9.7 | 74.8 ± 9.8 | 0.118 |
HbA1c, %, mean ± SD | 6.26 ± 1.82 | 6.19 ± 1.98 | 6.29 ± 1.76 | 0.033 |
LDL-c, mmol/L, mean ± SD | 2.82 ± 1.43 | 2.89 ± 1.43 | 2.78 ± 1.42 | <0.001 |
Hemoglobin, g/L, mean ± SD | 131.4 ± 22.5 | 131.3 ± 22.6 | 131.4 ± 22.4 | 0.687 |
eGFR, ml/min×1.73m2, mean ± SD | 87.1 ± 41.8 | 86.8 ± 41.2 | 87.3 ± 42.0, | 0.874 |
LVEF, %, mean ± SD | 55.1 ± 11.5 | 54.8 ± 11.5 | 55.3 ± 11.5 | 0.016 |
ACS | 87.9% | 87.5% | 88.0% | 0.424 |
Multibranch coronary lesions | 36.5% | 40.2% | 35.0% | <0.001 |
Interventional therapy | 57.7% | 62.4% | 55.9% | <0.001 |
Length of stay; d, mean ± SD | 8.03 ± 4.02 | 7.95 ± 3.79 | 8.07 ± 4.10 | 0.148 |
Hospital level | ||||
Tertiary hospital | 90.2% | 90.7% | 90.0% | 0.201 |